Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial

Ashish Sarraju, Danielle M. Brennan, Kierstyn Hayden, Amanda Stronczek, Anne C. Goldberg, Erin D. Michos, Darren K. McGuire, Denise Mason, Grace Tercek, Stephen J. Nicholls, Douglas Kling, Annie Neild, John J.P. Kastelein, Michael H. Davidson, Marc Ditmarsch, Steven E. Nissen